Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03685344
Recruitment Status : Recruiting
First Posted : September 26, 2018
Last Update Posted : March 1, 2019
Sponsor:
Information provided by (Responsible Party):
ADC Therapeutics S.A.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 8, 2020
  Estimated Study Completion Date : July 6, 2022